PMID- 24217842
OWN - NLM
STAT- MEDLINE
DCOM- 20141009
LR  - 20220310
IS  - 1972-6007 (Electronic)
IS  - 0009-9074 (Linking)
VI  - 164
IP  - 5
DP  - 2013
TI  - Hepatitis C virus infection and type 2 diabetes.
PG  - e393-404
LID - 10.7417/CT.2013.1620 [doi]
AB  - Hepatitis C virus (HCV) infection and Type 2 diabetes mellitus (T2DM) are two 
      worldwide, major public health problems with increasing complication and 
      mortality rates. Many epidemiological studies have demonstrated the significant 
      association between T2DM and chronic HCV infection. In this paper we have 
      reviewed the increasing evidence linking HCV infection and DM in more than one 
      field (epidemiology, pathogenesis, clinical aspects, prevention and treatment). 
      We have considered T2DM, acute and chronic HCV infection, and cirrhotic patients. 
      Moreover, we have considered some particular populations, solid organ transplant 
      recipients or HCV/human immunodeficiency virus (HIV) coinfected patients. In the 
      final part we have analyzed the potential effect of the association between HCV 
      infection and the development of DM in term of outcome and possibilities for 
      prevention and treatment.
FAU - Fallahi, P
AU  - Fallahi P
AD  - Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
FAU - Ferrari, S M
AU  - Ferrari SM
FAU - Colaci, M
AU  - Colaci M
FAU - Ruffilli, I
AU  - Ruffilli I
FAU - Vita, R
AU  - Vita R
FAU - Azzi, A
AU  - Azzi A
FAU - Ferri, C
AU  - Ferri C
FAU - Antonelli, A
AU  - Antonelli A
FAU - Ferrannini, E
AU  - Ferrannini E
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Italy
TA  - Clin Ter
JT  - La Clinica terapeutica
JID - 0372604
RN  - 0 (Immunosuppressive Agents)
RN  - IY9XDZ35W2 (Glucose)
SB  - IM
MH  - Autoimmune Diseases/etiology/immunology
MH  - Diabetes Mellitus, Type 1/etiology
MH  - Diabetes Mellitus, Type 2/prevention & control/*virology
MH  - Disease Susceptibility
MH  - Genotype
MH  - Glucose/metabolism
MH  - HIV Infections/epidemiology
MH  - Hepacivirus/genetics
MH  - Hepatitis C, Chronic/*complications/immunology/metabolism/prevention & control
MH  - Humans
MH  - Immunosuppressive Agents/adverse effects/therapeutic use
MH  - Liver/metabolism
MH  - Liver Cirrhosis/complications/metabolism/virology
MH  - Organ Transplantation
MH  - Postoperative Complications/etiology
MH  - Prevalence
MH  - Prognosis
MH  - Thyroid Diseases/etiology
EDAT- 2013/11/13 06:00
MHDA- 2014/10/10 06:00
CRDT- 2013/11/13 06:00
PHST- 2013/11/13 06:00 [entrez]
PHST- 2013/11/13 06:00 [pubmed]
PHST- 2014/10/10 06:00 [medline]
AID - 10.7417/CT.2013.1620 [doi]
PST - ppublish
SO  - Clin Ter. 2013;164(5):e393-404. doi: 10.7417/CT.2013.1620.